Pain Medication for Postoperative Pain
Trial Summary
What is the purpose of this trial?
This trial is testing whether adding Toradol, an anti-inflammatory drug, to the usual opioid painkillers can better manage pain after surgery in patients who have had a specific type of bone surgery. These patients are chosen because they don't need the body's natural inflammation process for healing. Toradol works by reducing inflammation, while opioids change how the brain perceives pain. Toradol, also known as ketorolac, is a nonsteroidal anti-inflammatory drug (NSAID) that has been studied for its opioid-sparing effects in postoperative pain management.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are currently using probenecid or pentoxifylline, or if you have certain medical conditions that prevent NSAID or toradol use.
What data supports the effectiveness of the drugs for postoperative pain?
Research shows that a combination of oxycodone, acetaminophen, and ketorolac can effectively control postoperative pain with fewer complications compared to using opioids alone. Additionally, intravenous acetaminophen and intranasal ketorolac are highlighted as effective components in a multimodal approach to pain management after surgery.12345
Is the pain medication safe for humans?
The combination of oxycodone and acetaminophen (Percocet) has been shown to have an improved safety profile with fewer side effects compared to oxycodone alone. Paracetamol (another name for acetaminophen) is also noted for providing effective pain relief with fewer side effects when used in combination with other pain medications.12367
How does the drug Hydrocodone/Acetaminophen, Morphine, Oxycodone differ from other drugs for postoperative pain?
This drug combination is unique because it includes both opioids (like Hydrocodone and Morphine) and non-opioid pain relievers (like Acetaminophen), providing a strong pain relief option for severe postoperative pain, but it carries a risk of addiction and side effects, unlike some non-opioid alternatives.89101112
Research Team
David Greenberg, MD
Principal Investigator
St. Louis University
Eligibility Criteria
This trial is for adults planning to undergo prophylactic intramedullary nailing of the femur due to bone lesions. It's not suitable for those with coagulation disorders, current fractures, severe kidney or liver disease, peptic ulcer disease, certain heart conditions, allergies to acetaminophen or NSAIDs, opioid addiction or dependence, pregnancy, and those on specific medications like probenecid.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive post-op pain management with either ketorolac and opioids or opioids alone following prophylactic intramedullary nailing of the femur
Follow-up
Participants are monitored for safety and effectiveness after treatment, including pain and functional assessments
Treatment Details
Interventions
- Acetaminophen (Analgesic)
- Hydrocodone/Acetaminophen (Opioid Analgesic)
- Ketorolac (Non-Steroidal Anti-Inflammatory Drug)
- Morphine (Opioid Analgesic)
- Oxycodone (Opioid Analgesic)
Hydrocodone/Acetaminophen is already approved in Canada for the following indications:
- Moderate to severe pain
Find a Clinic Near You
Who Is Running the Clinical Trial?
St. Louis University
Lead Sponsor
Dr. Laura Simpson
St. Louis University
Chief Medical Officer since 2023
PhD in Molecular and Cellular Biology from Tulane University
Dr. Keith Vendola
St. Louis University
Chief Executive Officer since 2023
PhD in Molecular Biology from Washington University in St. Louis